Target-controlled Infusions of Remifentanil and Propofol During Laparoscopic Cholecystectomy

Min LI,Min-hui WU,Zhanggang XUE,Hao JIANG
DOI: https://doi.org/10.3969/j.issn.0253-9934.2005.11.006
2005-01-01
Abstract:Objective To evaluate the clinical response of target-controlled infusion-based anesthesia using remifentanil and propofol. Methods 40 ASA Ⅰ-Ⅱ patients (21 male, 19 female) aged 65 yr undergoing elective laparoscopic cholecystectomy were randomly divided into two groups: group F and R, each 20 patients, without any preoperative medication in group F the target plasma concentration of propofol was set at 3 μg/ml and fentanyl at 4 μg/kg during induction and 2 μg/kg at the start of operation. In group R, the anesthesia was induced and maintained with TCI propofol-remifentanil which was stopped at the end of the operation. The target plasma concentration of propofol was set at 3 μg/ml and remifentanil at 6 ng/ml. The TCI system of Base Primea was used, including Marsh and Minto pharmacokinetic parameters. MAP, HR, EKG, BIS and AAIs were monitored during the anesthesia. The followings were recorded: ①changes in MAP, HR, EKG, BIS and AAIs during anesthesia; ②recovery of spontaneous breathing and orientation after termination of anesthesia; ③postoperative outcome, pain and complications including nausea, vomiting and awareness during the operations. Results During induction MAP, the HRs were significantly lower in group R than in group F (P0.05). BIS and AAIs during operation were not significantly different. The duration from termination of anesthetics to full recovery of spontaneous breathing, eye opening at request and tracheal extubation were similar between the two groups. Pain after operation was significantly higher in group R than that in group F. Conclusions Anesthesia with the target plasma propofol concentration of 3 μg/ml in the presence of plasma remifentanil of 6 ng/m is safe and effective. It can effectively attenuate the intubation response. Because of the shorter context-sensitive half life of remifentanil, postoperative analgesia should be started earlier.
What problem does this paper attempt to address?